University of Kentucky Mental Health Research Center at Eastern State Hospital, 627 West Fourth St., Lexington, KY 40508, USA.
Hum Genet. 2012 Jun;131(6):877-901. doi: 10.1007/s00439-011-1122-6. Epub 2011 Dec 22.
The association between schizophrenia and tobacco smoking has been described in more than 1,000 articles, many with inadequate methodology. The studies on this association can focus on: (1) current smoking, ever smoking or smoking cessation; (2) non-psychiatric controls or controls with severe mental illness (e.g., bipolar disorder); and (3) higher smoking frequency or greater usage in smokers. The association with the most potential for genetic studies is that between ever daily smoking and schizophrenia; it may reflect a shared genetic vulnerability. To reduce the number of false-positive genes, we propose a three-stage approach derived from epidemiological knowledge. In the first stage, only genetic variations associated with ever daily smoking that are simultaneously significant within the non-psychiatric controls, the bipolar disorder controls and the schizophrenia cases will be selected. Only those genetic variations that are simultaneously significant in the three hypothesis tests will be tested in the second stage, where the prevalence of the genes must be significantly higher in schizophrenia than in bipolar disorder, and significantly higher in bipolar disorder than in controls. The genes simultaneously significant in the second stage will be included in a third stage where the gene variations must be significantly more frequent in schizophrenia patients who did not start smoking daily until their 20s (late start) versus those who had an early start. Any genetic approach to psychiatric disorders may fail if attention is not given to comorbidity and epidemiological studies that suggest which comorbidities are likely to be explained by genetics and which are not. Our approach, which examines the results of epidemiological studies on comorbidities and then looks for genes that simultaneously satisfy epidemiologically suggested sets of hypotheses, may also apply to the study of other major illnesses.
精神分裂症与吸烟之间的关联在超过 1000 篇文章中已有描述,其中许多文章的方法学不够完善。关于这种关联的研究可以集中在以下几个方面:(1)当前吸烟、曾经吸烟或戒烟;(2)非精神科对照或严重精神疾病对照(如双相情感障碍);以及(3)吸烟频率更高或吸烟者使用量更大。与遗传研究最相关的关联是曾经每天吸烟与精神分裂症之间的关联;它可能反映了共同的遗传脆弱性。为了减少假阳性基因的数量,我们提出了一种基于流行病学知识的三阶段方法。在第一阶段,仅选择与曾经每天吸烟相关且同时在非精神科对照、双相情感障碍对照和精神分裂症病例中具有显著意义的遗传变异。仅在三个假设检验中同时具有显著意义的遗传变异将在第二阶段进行测试,其中这些基因在精神分裂症中的患病率必须显著高于双相情感障碍,并且在双相情感障碍中显著高于对照组。在第二阶段同时具有显著意义的基因将被纳入第三阶段,其中在 20 多岁才开始每天吸烟的精神分裂症患者(晚发)中,这些基因变异的频率必须明显高于那些很早就开始每天吸烟的患者。如果不关注共病和流行病学研究,即表明哪些共病可能由遗传解释,哪些不能由遗传解释,那么任何针对精神疾病的遗传方法都可能失败。我们的方法检查了共病的流行病学研究结果,然后寻找同时满足流行病学建议的假设集的基因,也可能适用于其他主要疾病的研究。